Titre :
  • Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: an EORTC phase III study (10863).
Auteur : Beex, Louk ; Rose, Carsten ; Mouridsen, Henning ; Jassem, J. ; Nooij, Marianne ; Estape, J. ; Paridaens, Robert ; Piccart-Gebhart, Martine ; Gorlia, Thierry ; Lardenoije, S. ; Baila, L.
Informations sur la publication : European journal of cancer, 42, 18, (page 3178-3185)
Statut de publication : Publié, 2006-12
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Advanced breast cancer
Alternated endocrine therapy
Intermittent endocrine therapy
Medroxyprogesterone acetate
Randomised study
Tamoxifen
Mots-clés MeSH : Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- drug therapy
Disease-Free Survival
Drug Resistance, Neoplasm
Female
Humans
Medroxyprogesterone Acetate -- administration & dosage
Medroxyprogesterone Acetate -- adverse effects
Middle Aged
Tamoxifen -- administration & dosage
Tamoxifen -- adverse effects
Note : Clinical Trial, Phase III
Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Langue :
  • Anglais
Identificateurs : urn:issn:0959-8049 
info:doi/10.1016/j.ejca.2006.08.020
info:pii/S0959-8049(06)00765-9
info:pmid/17045796